+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Urological Disorders Drugs Market Research Reports

Urinary Tract Infection Testing Devices Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Testing Devices Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Overactive Bladder- Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hematuria - Pipeline Insight, 2025 - Product Thumbnail Image

Hematuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Urolithiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Urolithiasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Overactive Bladder Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Stress Urinary Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Stress Urinary Incontinence - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
ULTOMIRIS Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

ULTOMIRIS Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
From
Hydroxyzine - Global Strategic Business Report - Product Thumbnail Image

Hydroxyzine - Global Strategic Business Report

  • Report
  • September 2025
  • 284 Pages
  • Global
From
Ceftriaxone - Global Strategic Business Report - Product Thumbnail Image

Ceftriaxone - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
Interstitial Cystitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Interstitial Cystitis Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 471 Pages
  • Global
From
From
Uropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Uropathy Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 271 Pages
  • Global
From
Male Urinary Incontinence - Global Strategic Business Report - Product Thumbnail Image

Male Urinary Incontinence - Global Strategic Business Report

  • Report
  • September 2025
  • 563 Pages
  • Global
From
Diuretic Drugs - Global Strategic Business Report - Product Thumbnail Image

Diuretic Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 372 Pages
  • Global
From
Nocturia Drugs - Global Strategic Business Report - Product Thumbnail Image

Nocturia Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 192 Pages
  • Global
From
Loading Indicator

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them. Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more